Inhibition of checkpoint kinase 1 potentiates anticancer activity of gemcitabine in bladder cancer cells
Abstract Checkpoint kinases (CHKs) are involved in the DNA damage response in many cancer cells. CHK inhibitors have been used in clinical trials in combination with chemotherapeutics; however, their effect against bladder cancer remains unclear. Here, we investigated the efficacy of combining gemci...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/961e795ec7d4455493f964a2d9a8fa35 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|